Hyogo Prefectural Nishinomiya Hospital
Nishinomiya, Hyogo, Japan
General hospital in Nishinomiya
13-9 Rokutanjicho, Nishinomiya, Hyogo 662-0918
About Hyogo Prefectural Nishinomiya Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
AgNovos Healthcare, LLC
1
Millennium Pharmaceuticals, Inc.
1
Takayuki Hamano
1
Clinical Trials at Hyogo Prefectural Nishinomiya Hospital
During the past decade, Hyogo Prefectural Nishinomiya Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients
2014-08-01
2016-12-01
Completed
90
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
2018-10-14
2021-07-15
Completed
242
Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
2020-11-18
2022-09-06
Completed
57
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
2021-04-24
2029-04-01
Recruiting
2,400
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
2021-09-21
2026-02-09
Recruiting
1,580
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hyogo Prefectural Nishinomiya Hospital"
#1 collaborator was "Akebono clinic" with 1 trials as a collaborator, "Avania" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "BioClinica, Inc." with 1 trials as a collaborator and "CMIC Co, Ltd. Japan" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Hyogo Prefectural Nishinomiya Hospital
According to Clinical.Site data, the most researched conditions in "Hyogo Prefectural Nishinomiya Hospital" are
"Anemia" (1 trials), "Bone Diseases, Metabolic" (1 trials), "Central Nervous System Pathology" (1 trials), "Diabetic Gastroparesis" (1 trials) and "Fragility Fracture" (1 trials). Many other conditions were trialed in "Hyogo Prefectural Nishinomiya Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Hyogo Prefectural Nishinomiya Hospital
Most popular intervention types in "Hyogo Prefectural Nishinomiya Hospital" are "Drug" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "AGN1 LOEP treatment" (1 trials), "BAY1747846" (1 trials), "Cholecalciferol" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hyogo Prefectural Nishinomiya Hospital
The vast majority of trials in "Hyogo Prefectural Nishinomiya Hospital" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hyogo Prefectural Nishinomiya Hospital
Currently, there are NaN active trials in "Hyogo Prefectural Nishinomiya Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hyogo Prefectural Nishinomiya Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hyogo Prefectural Nishinomiya Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".